Salles, G., Schuster, S. J., de Vos, S., Wagner-Johnston, N. D., Viardot, A., Blum, K. A., Flowers, C. R., Jurczak, W. J., Flinn, I. W., Kahl, B. S., Martin, P., Kim, Y., Shreay, S., Will, M., Sorensen, B., Breuleux, M., Zinzani, P. L. and Gopal, A. K. (2017) “Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study”, Haematologica. Pavia, Italy, 102(4), pp. e156-e159. doi: 10.3324/haematol.2016.151738.